Urinalysis & Toxicology

A New Urine Test Could Curtail Use of a New Synthetic Cannabinoid

A new study showed that a novel drug test can detect a new class of synthetic cannabinoids called OXIZIDs.

Urinalysis & Toxicology

Urine DNA Test Detects Bladder Cancer Data Shows

Promis Diagnostics recently presented data for CystoChek, a proprietary urine-based DNA methylation test of PENK for bladder cancer detection in hematuria.

Urinalysis & Toxicology

New Jersey Urology Opens Renovated Pathology Lab

New Jersey Urology (NJU) unveiled its newly renovated pathology laboratory, which offers a menu of services, including NGS and PCR testing.

Study: New Prostate Cancer Test Could Avoid Unnecessary Biopsies

Feb 26, 2021 | Prostate, Urinalysis & Toxicology

A urine test could have avoided one-third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study.

March/April 2020 Tech Guide: Urinalysis

Jan 28, 2021 | Urinalysis & Toxicology

The Tech Guide from the March/April 2020 issue of Clinical Lab Products features urinalysis tests and analyzers from companies including Abbott, Arkray USA, Beckman Coulter, Kova International, Siemens Healthineers, and Sysmex America.

Experts Discuss Essential Efforts of Clinical Laboratories to Fight Opioid Epidemic at AACC Meeting

Dec 16, 2020 | Mass Spectrometry, Research, Urinalysis & Toxicology

Scientific sessions during the virtual 2020 AACC Meeting & Expo will highlight clinical laboratories’ integral role in managing the opioid epidemic and the latest drug tests needed to do so.

Liver Condition Identified in Patients Using Urine Samples

Nov 18, 2020 | Research, Urinalysis & Toxicology

Fifty peptides have been identified in the urine of liver fibrosis patients in a new study that could pave the way for a potential diagnostic urine test for the condition.

Research Detects HULLK in Prostate Cancer

Nov 13, 2020 | Prostate, Research, Urinalysis & Toxicology

The study data provides a potential new approach to early detection of prostate cancer and an alternative to invasive biopsies.

Galaxy Diagnostics Launches Test for Direct Detection of Lyme Disease

Nov 13, 2020 | Emerging & Zoonotic Diseases, Urinalysis & Toxicology

Galaxy Diagnostics’ Nanotrap Urine Test for Lyme Borreliosis is a urine-based Lyme antigen test providing direct detection of Borrelia burgdorferi infection at all stages of the disease.

Amsbio Launches Human iPSC-derived Cells, Kits, and Services

Nov 2, 2020 | Urinalysis & Toxicology

These new human iPSC-derived products are based on a novel technology platform that relies on key transcription factor genes, a combination of which determines the identity of cells.

Molecules in Urine Could Allow Doctors to Monitor Skin Cancer

Aug 13, 2020 | Cancer, Urinalysis & Toxicology

Researchers have identified fluorescent molecules in urine that may allow patients with malignant melanoma to painlessly find out if treatment is working.

Sysmex to Distribute, Service Siemens Automated Urine Analyzer

Aug 11, 2020 | Company News, Urine Analyzers

An exclusive agreement grants Sysmex America North American rights to distribute and service Siemens Healthineers’ Clinitek Novus Automated Urine Analyzer.

Urine Test Could Help Assess Aspects of Cystic Fibrosis

Jul 25, 2020 | Respiratory Disease, Urinalysis & Toxicology

New research provides insights on the effects of cystic fibrosis in the kidneys, pointing to the potential for a urine test related to the disease.

Urine Test Could Offer Early Detection of Lung Tumors

Apr 8, 2020 | Lung Cancer, Urinalysis & Toxicology

A noninvasive urine test that can detect the presence of proteins linked to lung cancer could help detect more tumors in the early stages of the disease.

Liquid Stable, NIST-Traceable Urine Chemistry Standard Kit

Apr 6, 2020 | Calibrators, Quality Systems, Standards, Urinalysis & Toxicology

The five-level set of definitive standard reference materials contains eight separate components covering a total of 40 individual set points.

Mologic Launches Clinical Trial to Identify Early Signs of COPD

Jan 24, 2020 | Respiratory Disease, Urinalysis & Toxicology

The Headstart system is designed for home monitoring and integrates a simple, easy-to-use diagnostic with a reader and mobile phone app to capture patient-specific health data.